Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Effect of Ranibizumab Versus Bevacizumab on the Macular Perfusion in Diabetic Macular Edema Using OCTA

NCT04991350 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT04991350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04991350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Effect of Ranibizumab Versus Bevacizumab on the Macular Perfusion in Diabetic Macular Edema Using OCTA
Lead sponsor
Cairo University
Phase
Phase 4
Overall status
Terminated
Start date
November 26, 2021
Completion date
November 1, 2022
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema, diabetic retinopathy, macular ischemia, vascular endothelial growth factor overexpression